On this page
The verdict
If you are going to buy one of these, buy nicotinamide riboside — and hold that recommendation loosely, because neither belongs near the top of a supplement budget. NR does the one thing it advertises: 250–500 mg daily raises whole-blood NAD+ in a dose-dependent way, measurable within days and plateauing at roughly two weeks, and it has been through more controlled human safety work than most of what sits beside it on the shelf. Resveratrol has the better story and the worse pharmacology. It is absorbed readily and then dismantled almost immediately — the gut wall and liver attach sulfate and glucuronide groups within minutes, so very little unmodified compound reaches your tissues — and the dramatic findings that built its reputation come from yeast, worms, flies and mice rather than from people. Now read the sentence about NR again, because it is the whole page: raising a biomarker is not the same as producing a benefit. Neither compound has shown an effect a healthy adult would notice, in energy, in performance, or in anything you could feel from the inside. NR wins this matchup on measurement and on the cleaner interaction profile; resveratrol at 150–500 mg costs a fraction as much and carries genuine antiplatelet and estrogenic cautions that NR does not. And if the question behind the question is which one will help you age better, the honest answer is that nobody can tell you yet, and the money does more work in omega-3, vitamin D3, magnesium and creatine first.
These two sit in the same aisle, get sold on the same promise, and are not the same kind of bet. Resveratrol is a plant polyphenol — a stilbene that grapevines produce under stress, extracted commercially from Japanese knotweed rather than from anything that ever saw a vineyard, and taken as trans-resveratrol, the isomer the research used. Nicotinamide riboside is a form of vitamin B3 that your cells convert into NAD+, the coenzyme every cell uses to move electrons through energy metabolism and the raw material two enzyme families, sirtuins and PARPs, consume rather than recycle. One is a signaling molecule with a pharmacokinetics problem. The other is a precursor to a cofactor, and it arrives where it is meant to.
The evidence has a distinctive shape in each case, and knowing the shape is most of what you need. Resveratrol's spectacular results are almost entirely non-human: lifespan extension in short-lived organisms, metabolic improvements in rodents fed badly on purpose, and a sirtuin-activation mechanism whose founding laboratory assay was later argued to be an artifact of the tagged substrate it used. In people, the same compound produces small and inconsistent movement in vascular and inflammatory markers. NR has the opposite problem. The biochemistry is nailed down and the outcomes are not: placebo-controlled trials reliably show blood NAD+ climbing on 250–500 mg a day, while trials measuring what people actually want from that — fatigue, exercise capacity, mitochondrial function — have come back mixed and mostly modest.
So this is not a search for a winner so much as a question of which unfinished bet is better built and what it costs to hold. What follows compares them on the axes that decide it: what reaches your tissues, what has been measured in humans rather than in mice, what a month costs, and which of the two carries cautions you need to clear with a clinician before you start.
Resveratrol vs Nicotinamide Riboside, side by side
| Criterion | Resveratrol | Nicotinamide Riboside |
|---|---|---|
| What it is | A stilbene polyphenol from grape skins and Japanese knotweed. The studied form is trans-resveratrol, which light and heat degrade into a less-active configuration | A form of vitamin B3 your cells convert into NAD+, the coenzyme energy metabolism runs on. Sold as nicotinamide riboside chloride |
| What has actually been measured in humans | Small, inconsistent shifts in flow-mediated dilation and circulating inflammatory markers. Single doses raise frontal blood flow during mental tasks — usually without any matching improvement in how people performed | A clear, dose-dependent rise in whole-blood NAD+, detectable within days and plateauing at about two weeks. That is a biomarker moving, not a benefit arriving |
| Absorption and metabolism | The weak point. Absorbed well, then sulfated and glucuronidated by the gut wall and liver within minutes, so little unmodified compound reaches tissue. Whether the metabolites do useful work is unresolved | Good. Small, stable, and into the salvage pathway in two enzymatic steps. The dose you swallow demonstrably moves the thing it is supposed to move |
| Where the evidence is strong, and where it stops | Strong in cells and animals; emerging at best in humans, and the sirtuin mechanism behind the reputation is contested rather than established | Strong for the biomarker and for short-term tolerability in controlled trials. Emerging to absent for any outcome a person would notice |
| Typical daily dose | 150–500 mg trans-resveratrol with a fat-containing meal; split it above 500 mg. Trials ran roughly 75–1,000 mg, with tolerability work higher | 250–500 mg in the morning, with or without food. Trials ran 100–2,000 mg, and no outcome benefit is documented above 500 mg for general use |
| Cost per month | Roughly $10–25 at 250–500 mg of a properly standardized extract | Roughly $25–60 at 250–500 mg. One of the more expensive things you can put on a daily shelf |
| Safety and interaction profile | More to clear first. Mild antiplatelet activity, estrogenic activity, and influence on drug-metabolizing liver enzymes at the top of the range. Off the table in pregnancy | Cleaner on paper — well tolerated in controlled trials, including at doses well above the everyday range. The open question is NAD+ and cell proliferation, which matters under oncology care |
| Who it suits | Someone drawn to the vascular and polyphenol side, on a small budget, not on blood thinners, with no hormone-sensitive concern | Someone who wants the mechanism they are paying for to be verifiable, has money left after the well-evidenced basics, and will accept feeling nothing |
Which one to choose
Choose Resveratrol if…
- The vascular and inflammatory-marker research is what interests you, rather than the NAD+ story, and you would rather buy the cheaper of two unfinished bets.
- Budget decides it. At 250–500 mg resveratrol costs a fraction of what NR costs, and since neither is going to produce a felt effect, paying several times more for the better-measured mechanism may not be worth it to you.
- You are already building a polyphenol-leaning routine alongside things like curcumin and tea catechins, and you understand you are buying plant chemistry rather than a proven intervention.
- You take no anticoagulant or antiplatelet medication, have no hormone-sensitive concern, and are not pregnant, nursing or trying to conceive — because those cautions are the real gate on this one, not the price.
Choose Nicotinamide Riboside if…
- You want the thing you are paying for to be measurable. NR raises blood NAD+ and that is documented in placebo-controlled work; very little else in this aisle can say as much about its own mechanism.
- You are over 55, where baseline NAD+ is lower and where the more interesting human trials have run — with the caveat that those trials are small, short, and have not replicated consistently.
- Resveratrol's platelet effect or estrogenic activity makes it a conversation you would rather not have. NR's interaction profile is the more straightforward of the two.
- The well-supported basics are already covered — omega-3, vitamin D3, magnesium, creatine — and this is discretionary money you are comfortable putting on an unfinished hypothesis.
- You would rather have a compound with a real controlled-trial safety record than one with a better story.
Relevant stacks
- Resveratrol has mild antiplatelet activity — this is documented, not theoretical. If you take anticoagulant or antiplatelet medication, or you have a bleeding disorder, clear it with your prescriber before starting, and ask your pharmacist to review it against your full list. Tell your surgical or dental team what you take: a pause of roughly two weeks before a procedure is the standard precaution for compounds that affect platelet function.
- Resveratrol is a phytoestrogen with real estrogen-receptor activity. If you have a hormone-sensitive condition, use hormonal contraception or hormone therapy, or are under oncology care, that decision belongs with your clinician rather than with an article. Neither compound is appropriate in pregnancy or while nursing — resveratrol because of the estrogenic activity and the absence of safety data, NR because it has simply never been studied in that population.
- NAD+ availability interacts with cell proliferation and DNA repair, and that question is genuinely unresolved in the research. Anyone with a personal history of cancer, or currently under oncology care, should raise NAD+ precursors with their oncology team before starting rather than after.
- Significant liver or kidney impairment changes how B3 derivatives are handled, and resveratrol at the upper end of its range can influence the liver enzymes that process a broad range of medications. If you take any prescription at all, have your pharmacist look at the whole list instead of assuming that a vitamin derivative and a plant polyphenol are inert.
- This page is written for adults 18 and over. A compound with estrogenic activity has no place in a developing endocrine system, there is no pediatric evidence behind either of these, and supplement bottles belong out of reach of children as a matter of routine.
- Spend in the right order. These are two of the more expensive ways to buy an unfinished hypothesis, and the honest framing is that you will not feel either one working. If your budget covers a handful of compounds, omega-3, vitamin D3, magnesium and creatine are far better-supported places to put the money — and we would rather tell you that than sell you the one with the better story.
Frequently asked questions
Resveratrol vs NAD supplement — which one actually works?
It depends entirely on what you mean by works. NR does what it claims at the biochemical level: 250–500 mg daily raises whole-blood NAD+ in placebo-controlled trials, within days, plateauing around two weeks. Resveratrol has never demonstrated a comparably reliable effect on anything in humans, largely because so little of it survives first-pass metabolism. But neither has shown an outcome a healthy adult would notice. If you want a verifiable mechanism for your money, NR. If you want to feel a difference, neither.
Can I take resveratrol and NR together?
Yes, and blends selling both are everywhere. Two warnings. The combination is marketed on a theory — resveratrol activating sirtuins that NAD+ then feeds — and that theory rests on a contested mechanism, so the pairing is not the multiplier the packaging implies. And blends are where doses go to hide: read the milligrams of trans-resveratrol and of nicotinamide riboside chloride separately, because a proprietary longevity matrix routinely delivers a fraction of either studied amount.
Is either one an anti-aging supplement?
Both are sold that way and neither has human outcome data showing it changes how anyone ages. Resveratrol's lifespan findings come from yeast, worms, flies and mice, and the sirtuin mechanism behind them may have been an artifact of the original assay. NR's case rests on the observation that tissue NAD+ declines with age plus the assumption that pushing it back up matters — a reasonable assumption that remains an assumption. Buy either as a long-shot bet on a mechanism you find plausible, or skip both.
Why is resveratrol's absorption such a problem?
It crosses out of the gut perfectly well and is then taken apart almost immediately. Sulfate and glucuronide groups get attached within minutes, so very little unmodified resveratrol reaches tissue; what circulates is mostly conjugated metabolites whose activity is an open question. Micronized, liposomal and piperine-paired versions do raise measured blood levels, but none has yet shown that the higher number produces a better human result.
Is NR better than NMN?
Nobody knows, and that is the accurate answer rather than a hedge. Both raise blood NAD+ in humans. NR has more controlled human safety data and a clearer regulatory position in the US. NMN sits one enzymatic step closer to NAD+ in the pathway, which sounds decisive and has not proven to be. Anyone telling you the comparison is settled is ahead of the evidence, including people selling either one.
Can I get resveratrol from red wine instead?
No, and it is not close. A glass supplies roughly 0.1–1 mg while human trials used 75–1,000 mg, so reaching a single 250 mg dose would take several hundred glasses at the generous end of that estimate and a few thousand at the realistic one. The alcohol would arrive long before the resveratrol did. Drink wine because you like wine; it is not a delivery system for this compound.
Written for adults aged 18 and over. This content is for education only and is not medical advice. Supplements are not intended to diagnose, treat, cure, or prevent any disease. Talk with your clinician before starting any supplement, especially if you are pregnant, nursing, taking medication, or managing a health condition. Supplements for children are a pediatric clinician's decision — keep all supplements out of reach of children.
Our medical advisor is Dr. Garrett Wdowin, NMD, ABAAHP, FAARM, naturopathic doctor. This page has not been medically reviewed.